Health&Beauty- Page 33

The FINANCIAL -- A new study by scientists at the University of Liverpool highlights how a clinically-approved lung cancer drug could potentially be ‘repurposed’ to design new treatments for future cancer therapies.

The FINANCIAL -- Unlike other bodily tissues, the cornea isn't laced with blood vessels for nourishment or to ward o­ infection. Instead, the cornea requires a perfect balance of tear coverage and fluid movement to remain healthy.

The FINANCIAL -- Gilead Sciences, Inc. announced plans to launch authorized generic versions of Epclusa (sofosbuvir 400mg/velpatasvir 100mg) and Harvoni (ledipasvir 90mg/sofosbuvir 400mg), Gilead’s leading treatments for chronic hepatitis C virus (HCV), in the United States, through a newly created subsidiary, Asegua

The FINANCIAL -- AstraZeneca today announced positive results from the Phase III DECLARE-TIMI 58 cardiovascular (CV) outcomes trial (CVOT) for Farxiga (dapagliflozin), the broadest SGLT2 inhibitor CVOT conducted to date.

The FINANCIAL -- Study researchers say that retinoblastoma forms from mutations in the RB1 gene and the loss of functional RB protein.

The FINANCIAL -- New research from the London School of Economics and Political Science (LSE) has found that providing additional training for health visitors to prevent new mothers from developing symptoms of postnatal depression resulted in significant cost-savings. The effect on mothers’

The FINANCIAL -- It’s been three years since the SDGs were adopted and we’ve seen some great progress. But it’s not enough. Pneumonia and diarrhoea continue to be two of the leading killers of children worldwide. Together, they are responsible for almost

The FINANCIAL -- Basel, September 12, 2018 - Novartis, one of the  leaders in immuno-dermatology, announced new data from a patient preference survey showing psoriasis patients want their treatment to go beyond just clear skin and safety. 

The FINANCIAL -- Evidence-based clinical practice guidelines ensure optometry has the latest care recommendations available to provide maximal, timely patient care - no matter where doctors are in their career.

The FINANCIAL-- If Americans needed another reason to get up and get active, it's this: Physical activity, even just the bare minimum, may lessen glaucoma risk and its threat of vision loss, research finds.